Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors. (Q52027015)
Jump to navigation
Jump to search
scientific article published in March 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors. |
scientific article published in March 2000 |
Statements
1 reference
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors. (English)
1 reference
1 reference
Messer WS Jr
1 reference
Rajeswaran WG
1 reference
Cao Y
1 reference
Zhang HJ
1 reference
el-Assadi AA
1 reference
Dockery C
1 reference
Liske J
1 reference
O'Brien J
1 reference
Williams FE
1 reference
Wroblewski ME
1 reference
Nagy PI
1 reference
Peseckis SM
1 reference
1 March 2000
1 reference
74
1 reference
2-3
1 reference
135-140
1 reference
Identifiers
1 reference